Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRNX | Common Stock | Options Exercise | $8.27K | +5.7K | +45.47% | $1.45* | 18.2K | Jul 13, 2022 | Direct | F1 |
transaction | CRNX | Common Stock | Sale | -$119K | -5.7K | -31.26% | $20.96 | 12.5K | Jul 13, 2022 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRNX | Non-qualified stock option (Right to Buy) | Options Exercise | $0 | -5.7K | -100% | $0.00* | 0 | Jul 13, 2022 | Common stock | 5.7K | $1.45 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date. |
F2 | The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of November 6, 2017. |